跳到正文

Keros Therapeutics, Inc.(KROS)内部人交易:高管与董事近期交易

过去 18 个月,共有 28 位内部人为 Keros Therapeutics, Inc.(KROS)报告了 106 笔 Form 4 交易(最近一笔 2026-11-19)。

日期内部人职务类型股数市值
2026-11-19Prener Anne董事卖出433$4,663
2026-11-19Newton Charles W.董事卖出491$5,318
2026-11-19Prener Anne董事卖出142$1,566
2026-11-19Newton Charles W.董事卖出60$663
2026-11-16Prener Anne董事卖出574$5,619
2026-08-20Newton Charles W.董事卖出551$5,675
2026-08-20Lerner Lorena RaquelChief Scientific Officer卖出3,568$36,715
2026-08-20Cho EstherChief Legal Officer卖出4,485$46,151
2026-08-20Tanini AnnitaCorp. Controller & VP, Finance卖出1,224$12,595
2026-08-19BIENAIME JEAN JACQUES董事买入1,000$10,270
2026-07-17BIENAIME JEAN JACQUES董事买入1,000$10,610
2026-07-06Prener Anne董事买入13,786$0
2026-06-17BIENAIME JEAN JACQUES董事买入1,000$10,190
2026-06-15Newton Charles W.董事卖出550$5,522
2026-06-08Farzan Nima董事卖出2,625$28,166
2026-06-08Knowles Julius董事卖出2,625$28,166
2026-06-05Seth Alpna董事买入7,142$0
2026-06-05BIENAIME JEAN JACQUES董事买入7,142$0
2026-06-05Farzan Nima董事买入7,142$0
2026-06-05Knowles Julius董事买入7,142$0
2026-06-05Seth Alpna董事卖出2,625$28,140
2026-06-05GRAY MARY ANN董事买入7,142$0
2026-05-19BIENAIME JEAN JACQUES董事买入1,000$10,580
2026-04-17BIENAIME JEAN JACQUES董事买入1,000$11,700
2026-04-06Seehra JasbirCHIEF EXECUTIVE OFFICER买入55,000$16,500

来源:SEC Form 4 申报文件 · 截至 2026-11-19